Related Experiment Video

Updated: Aug 20, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Modulation of retrovirally driven therapeutic genes by mutant TP53 in anaplastic thyroid carcinoma

Luisa Barzon1, Elisa Gnatta, Ignazio Castagliuolo

  • 1Department of Histology, Microbiology, and Medical Biotechnologies, University of Padova, I-35121 Padova, Italy.

Cancer Gene Therapy
|January 15, 2005
PubMed

Insights

TP53 status influences gene therapy in anaplastic thyroid carcinoma. Wild-type TP53 enhances expression from thyroid-specific promoters, while TP53 defects favor retroviral LTR vectors for therapeutic gene delivery.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • Anaplastic thyroid carcinoma (ATC) often harbors TP53 mutations.
  • Restoring TP53 activity in ATC inhibits cell growth and promotes differentiation.
  • The impact of TP53 status on therapeutic gene expression requires further investigation.

Purpose of the Study:

  • To investigate if TP53 status affects the expression of therapeutic genes driven by retroviral LTR or tissue-specific enhancers.
  • To determine optimal vector strategies for gene therapy in ATC based on TP53 status.

Main Methods:

  • Transfection of TP53-defective ARO ATC cells with wild-type TP53 (TP53(Val135)).
  • Transduction with retroviral vectors containing therapeutic genes under control of wild-type LTR or a thyroglobulin (TG) enhancer.
  • Evaluation of transgene expression at different temperatures (37°C and 32°C) and with TSH treatment.
  • Assessment of ganciclovir-induced cytotoxicity.

Main Results:

  • Transgene expression from TG enhancer was 10-fold lower than from wild-type LTR.
  • TP53 transfer repressed wild-type LTR but enhanced TG-driven gene expression.
  • This enhancement was potentiated by 32°C culture and TSH treatment.
  • Cytotoxicity correlated with therapeutic gene expression levels.

Conclusions:

  • TP53 status significantly influences therapeutic gene expression in ATC.
  • Wild-type LTR vectors are suitable for targeting TP53-defective ATC.
  • Thyroid-specific promoters are effective for targeting ATC with wild-type TP53.

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...